In patients heterozygous for abnormal hemoglobins there is usually less than 50% of the mutant hemoglobin present in peripheral blood. The synthetic rates of α-chain mutants compared to αA have not been reported to date. In this study the production of αA- and αI-chains has been measured in peripheral blood and bone marrow of two patients with approximately 30% hemoglobin I, an α-chain abnormality (α16 lys → glu). The results suggest that the decreased amount of αI compared to αA is due solely to diminished biosynthesis of the αI-chains. The relative rates of synthesis of αI- and αA-chains are similar in both nucleated red cells and reticulocytes indicating that no change occurs during erythroid cell maturation which preferentially affects either αI or αA production.
G. J. Folayan Esan, F. J. Morgan, J. V. O'Donnell, S. Ford, A. Bank
Usage data is cumulative from November 2023 through November 2024.
Usage | JCI | PMC |
---|---|---|
Text version | 142 | 0 |
107 | 35 | |
Scanned page | 176 | 14 |
Citation downloads | 58 | 0 |
Totals | 483 | 49 |
Total Views | 532 |
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.